Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
Joint Authors
Yeh, M.
Cheng, Lin
Liu, Yajuan
Wang, Wenjing
Merritt, J. L.
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-10-02
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Ornithine transcarbamylase (OTC) deficiency is an X-linked recessive disorder that leads to hyperammonemia and liver damage.
Hepatocellular adenoma in OTC deficiency patients has not been previously described.
Here we report the first such case to be described in the English language scientific literature.
American Psychological Association (APA)
Cheng, Lin& Liu, Yajuan& Wang, Wenjing& Merritt, J. L.& Yeh, M.. 2019. Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency. Case Reports in Hepatology،Vol. 2019, no. 2019, pp.1-6.
https://search.emarefa.net/detail/BIM-1136785
Modern Language Association (MLA)
Cheng, Lin…[et al.]. Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency. Case Reports in Hepatology No. 2019 (2019), pp.1-6.
https://search.emarefa.net/detail/BIM-1136785
American Medical Association (AMA)
Cheng, Lin& Liu, Yajuan& Wang, Wenjing& Merritt, J. L.& Yeh, M.. Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency. Case Reports in Hepatology. 2019. Vol. 2019, no. 2019, pp.1-6.
https://search.emarefa.net/detail/BIM-1136785
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1136785
